Men 25-35 TB-500 Protocol: Dosing Comparison
Loading Phase 2.5–5mg Twice weekly (e.g. Mon/Thu) 2–4 weeks Saturates actin-binding pathways, initiates angiogenesis at injury sites Front-loads tissue repair. Measurable symptom improvement typically appears week 2-3 Maintenance Phase 2–2.5mg Once weekly 4–8
This comparison does not assign a generated winner or score.
- Loading Phase
- 2.5–5mg
- Twice weekly (e.g. Mon/Thu)
- 2–4 weeks
- Saturates actin-binding pathways, initiates angiogenesis at injury sites
- Front-loads tissue repair. Measurable symptom improvement typically appears week 2-3
- Maintenance Phase
- 2–2.5mg
- Once weekly
- 4–8 weeks
- Sustains VEGF expression, supports collagen remodelling without overstimulation
- Maintains repair without diminishing returns. Most cost-effective phase
- Acute Injury Protocol
- 5mg loading → 2mg maintenance
- Twice weekly → once weekly
- 6–8 weeks total
- Aligns dosing with inflammatory and proliferative phases of healing
- Best for Grade I-II strains, post-surgical recovery, or single-event trauma
- Chronic Overuse Protocol
- 2.5mg loading → 2mg maintenance
- 8–12 weeks total
- Lower doses over longer duration reduce cost while addressing slow-healing tendinopathy
- Appropriate for rotator cuff issues, patellar tendinosis, Achilles tendinopathy